Page - 127 - in Advances in Neuroimmunology

BrainSci. 2016,6, 23 77. Bongarzone,E.R.; Byravan,S.;Givogri,M.I.; Schonmann,V.;Campagnoni,A.T.Platelet-derivedgrowth factorandbasicfibroblastgrowthfactor regulatecellproliferationandtheexpressionofnotch-1receptor in anewoligodendrocytecell line. J.Neurosci. Res. 2000,62, 319–328. [CrossRef] 78. Kim,H.;Shin, J.;Kim,S.;Poling, J.;Park,H.C.;Appel,B.Notch-regulatedoligodendrocytespecificationfrom radialglia in thespinalcordofzebrafishembryos.Dev.Dyn. 2008,237, 2081–2089. [CrossRef] [PubMed] 79. Shimizu,T.;Kagawa,T.;Wada,T.;Muroyama,Y.;Takada,S.; Ikenaka,K.Wntsignalingcontrols the timing ofoligodendrocytedevelopment in thespinalcord.Dev. Biol. 2005,282, 397–410. [CrossRef] [PubMed] 80. Zhang,Z.-H.;Li, J.-J.;Wang,Q.-J.;Zhao,W.-Q.;Hong, J.;Lou,S.-j.;Xu,X.-H.WNK1is involvedinNogo66 inhibitionofOPCdifferentiation.Mol.Cell.Neurosci. 2015,65, 135–142. [CrossRef] [PubMed] 81. Bhat,N.R.;Zhang,P.;Mohanty,S.B.P38mapkinaseregulationofoligodendrocytedifferentiationwithcreb asapotential target.Neurochem.Res. 2007,32, 293–302. [CrossRef] [PubMed] 82. Chew,L.J.;Coley,W.;Cheng,Y.;Gallo,V.Mechanismsof regulationofoligodendrocytedevelopmentbyp38 mitogen-activatedproteinkinase. J.Neurosci. 2010,30, 11011–11027. [CrossRef] [PubMed] 83. Flores, A.I.; Narayanan, S.P.; Morse, E.N.; Shick, H.E.; Yin, X.; Kidd, G.; Avila, R.L.; Kirschner, D.A.; Macklin,W.B.Constitutively active akt induces enhancedmyelination in the cns. J. Neurosci. 2008, 28, 7174–7183. [CrossRef] [PubMed] 84. Mitew,S.;Hay,C.M.;Peckham,H.;Xiao, J.;Koenning,M.;Emery,B.Mechanismsregulatingthedevelopment ofoligodendrocytesandcentralnervoussystemmyelin.Neuroscience2014,276, 29–47. [CrossRef] [PubMed] 85. Tanaka, T.; Yoshida, S. Mechanisms of remyelination: Recent insight from experimental models. Biomol.Concepts2014,5, 289–298. [CrossRef] [PubMed] 86. Wu, J.Q.;Saksena,M.M.;Soriano,V.;Vispo,E.; Saksena,N.K.Differential regulationofcytotoxicitypathway discriminatingbetweenHIV,HCVmono-andco-infection identifiedbytranscriptomeprofilingofPBMCs. Virol. J.2015,12, 1–16. [CrossRef] [PubMed] 87. Weiser,K.;Barton,M.;Gershoony,D.;DasGupta,R.;Cardozo,T.;Tang,S.-J.HIV’snef interactswithβ-catenin of thewntsignalingpathwayinhek293cells.PLoSONE2013,8, e77865. [CrossRef] [PubMed] 88. Richards,M.H.; Narasipura, S.D.; Kim, S.; Seaton,M.S.; Lutgen, V.; Al-Harthi, L.Dynamic interaction between astrocytes and infiltratingPBMCs in context of neuroAIDS.Glia 2015, 63, 441–451. [CrossRef] [PubMed] 89. Zhang,Y.;Argaw,A.T.;Gurfein,B.T.;Zameer,A.;Snyder,B.J.;Ge,C.;Lu,Q.R.;Rowitch,D.H.;Raine,C.S.; Brosnan, C.F.; et al. Notch1 signaling plays a role in regulating precursor differentiation duringCNS remyelination.Proc.Natl. Acad. Sci.USA2009,106, 19162–19167. [CrossRef] [PubMed] 90. Curry,C.L.; Reed, L.L.; Golde, T.E.;Miele, L.; Nickoloff, B.J.; Foreman,K.E.Gammasecretase inhibitor blocksnotchactivationandinducesapoptosis inkaposi's sarcomatumorcells.Oncogene2005,24, 6333–6344. [CrossRef] [PubMed] 91. Liu,Y.;Han,S.S.;Wu,Y.;Tuohy,T.M.;Xue,H.;Cai, J.;Back,S.A.;Sherman,L.S.;Fischer, I.;Rao,M.S.CD44 expression identifiesastrocyte-restrictedprecursorcells.Dev. Biol. 2004,276, 31–46. [CrossRef] [PubMed] 92. Tuohy,T.M.;Wallingford,N.;Liu,Y.;Chan,F.H.;Rizvi,T.;Xing,R.;Bebo,B.;Rao,M.S.; Sherman,L.S.CD44 overexpressionbyoligodendrocytes:Anovelmousemodelof inflammation-independentdemyelination anddysmyelination.Glia2004,47, 335–345. [CrossRef] [PubMed] 93. Suyama,M.;Daikoku,E.;Goto,T.;Sano,K.;Morikawa,Y.ReactivationfromlatencydisplaysHIVparticle buddingatplasmamembrane,accompanyingCD44upregulationandrecruitment.Retrovirology2009,6, 63. [CrossRef] [PubMed] 94. Chao, C.; Silverberg,M.J.; Xu, L.; Chen, L.H.; Castor, B.; Martinez-Maza,O.; Abrams,D.I.; Zha,H.D.; Haque,R.;Said, J.Acomparativestudyofmolecularcharacteristicsofdiffuse largeb-cell lymphomafrom patientswithandwithouthumanimmunodeficiencyvirus infection.Clin. CancerRes. 2015,21, 1429–1437. [CrossRef] [PubMed] 95. Fields, J.;Dumaop,W.;Langford,T.D.;Rockenstein,E.;Masliah,E.Roleofneurotrophic factoralterations in theneurodegenerativeprocess inHIVassociatedneurocognitivedisorders. J.NeuroimmunePharmacol. 2014, 9, 102–116. [CrossRef] [PubMed] 96. Peferoen,L.;Kipp,M.;vanderValk,P.;vanNoort, J.M.;Amor,S.Oligodendrocyte-microgliacross-talk in thecentralnervoussystem. Immunology2014,141, 302–313. [CrossRef] [PubMed] 127